Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its... see more

TSXV:KNE - Post Discussion

Kane Biotech Inc. > KANE BIOTECH ANNOUNCES STRONG POSITIVE RESULTS OF DERMAKB
View:
Comment by MirrorWorldMan on Apr 29, 2021 3:10pm
yeah, good news and those trial participants are now future customers. Nice way to jump start a product launch.  I wonder how high the share price would be if they didn't do that last placement. Significant volumes are traded but so much dumpage as well.  You think the asks will start being depleted by now..
Comment by cleareye on Apr 29, 2021 5:04pm
I love the controlled, steady increase of share price. It makes charting so easy! I agree, Mirrorworldman, great way to launch a product. cleareye.
Comment by MirrorWorldMan on May 03, 2021 11:52am
The nice large volume buy at the start of the week is a good way to start a Monday. Someone did their homework over the weekend and decided to get in. 
Kane Biotech Inc.